...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: believe today was one of zens largest volume days in a long time

 - around 50k sharess - up a penny. Ave daily vol is usally well under 10k i believe - if volume & price continue to increase daily maybe we do see something by the AGM......

Share
New Message
Please login to post a reply